Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 30, 2020
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesEun Young Kang, Dane Cheasley, Cecile LePage, et al.
Cancer|March 6, 2019
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special ConferenceRobert C Bast, Ursula A Matulonis, Anil K Sood, et al.
Gynecologic Oncology|November 11, 2022
Profiling the immune landscape in mucinous ovarian carcinomaNicola S Meagher, Phineas Hamilton, Katy Milne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 18, 2021
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer SurvivalKatharine K Brieger, Minh Tung Phung, Bhramar Mukherjee, et al.
Nature Methods|September 24, 2005
The External RNA Controls Consortium: a progress reportShawn C Baker, Steven R Bauer, Richard P Beyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.
British Journal of Cancer|October 29, 2014
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studyM Köbel, J Madore, S J Ramus, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
The Journal of Clinical Investigation|October 29, 2024
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancerBrad H Nelson, Phineas Hamilton, Minh Tung Phung, et al.
Pageof 23